Sofia Martinez
Neoplasia, also known as a neoplastic process, is the process of abnormal growth that starts from a single altered cell. The word neoplastic comes from the Greek neo, meaning new, and plastic, meaning formed or molded. Neoplasia is a unique form of genetic disease characterised by the accumulation of multiple somatic mutations in a population of cells undergoing neoplastic transformation. Neoplastic transformation is initiated by an insult to a normal cell, which could be from an exogenous agent such as a chemical carcinogen or radiation, or from an endogenous source such as reactive oxygen species. This initial insult leads to genetic alterations and/or epigenetic changes, resulting in selective clonal expansion and the development of a preneoplastic lesion. With additional genetic and epigenetic changes, cells with invasive potential emerge and a malignant tumour forms.
| Characteristics | Values |
|---|---|
| Neoplasm | A synonym of tumour |
| Neoplasia | The process of formation of neoplasms/tumours |
| Origin of the word Neoplastic | Greek neo 'new' and plastic 'formed, moulded' |
| Origin of the word Tumour | Latin noun tumour 'a swelling', ultimately from the verb tumēre 'to swell' |
| Neoplastic transformation | Initiated by an insult to a normal cell |
| Types of insults | Exogenous agent (chemical carcinogen or radiation) or endogenous source (reactive oxygen species) |
| Neoplasms | Often heterogeneous and contain more than one type of cell |
| Initiation and growth of Neoplasms | Dependent on a single population of neoplastic cells |
| Neoplastic cells | Must first develop the capacity to invade before they can metastasize |
| Neoplasia | Abnormal growth that starts from a single altered cell |
Explore related products
What You'll Learn
- Neoplasia: The process of abnormal growth that starts from a single altered cell
- Neoplastic transformation: Initiated by an insult to a normal cell, leading to genetic alterations and the development of cancerous cells
- Neoplastic disease: A multi-step process where cells acquire increasingly abnormal behaviours, leading to cancer
- Neoplastic cells and metastasis: Neoplastic cells must develop the capacity to invade before they can spread to other parts of the body
- Neoplastic growth: Angiogenesis, or the formation of new blood vessels, is a critical mediator of neoplastic growth, supplying nutrients and oxygen
Neoplasia: The process of abnormal growth that starts from a single altered cell
Neoplasia is the process of abnormal growth that starts from a single altered cell. The term is derived from the Greek "neo", meaning "new", and "plasia", meaning "tissue". Neoplasia, or the neoplastic process, refers to the formation of neoplasms or tumours. Tumours, from the Latin "tumour" meaning "swelling", are abnormal masses of tissue that result from cells dividing more than they should or failing to die when they should. Neoplasms can be benign or malignant. While benign neoplasms can only grow locally, malignant neoplasms can spread by invasion or metastasis.
The development of neoplastic disease is a multi-step process. It is initiated by an insult to a normal cell, which could be from an exogenous agent like a chemical carcinogen or radiation, or from an endogenous source like reactive oxygen species. This initial insult leads to genetic alterations and/or epigenetic changes, resulting in a preneoplastic lesion. Genetic and epigenetic lesions are integral parts of the processes of neoplastic transformation, tumourigenesis, and tumour progression. Genomic instability is a commonly occurring process during the development of neoplastic disease, and several forms of molecular alteration have been observed in human cancers, including gene amplifications, deletions, insertions, rearrangements, and point mutations.
With each subsequent mutation or epimutation, a new clonal outgrowth with greater proliferative potential arises. This process of clonal expansion driven by mutation or epimutation eventually leads to the formation of malignant tumours. Specific genetic alterations have been correlated with each stage of tumour development and progression. However, it is important to note that not all neoplasms form tumours; for example, leukemia and most forms of carcinoma in situ do not.
Angiogenesis, or the formation of new blood vessels, is an important mediator of neoplastic growth. Neovascularization supplies nutrients and oxygen, and newly formed capillary endothelial cells secrete polypeptide growth factors that stimulate neoplastic cell growth. Research has shown a correlation between the extent of angiogenesis and the probability of metastasis.
Best Plastic Fillers: The Ultimate Guide
You may want to see also
Explore related products
Neoplastic transformation: Initiated by an insult to a normal cell, leading to genetic alterations and the development of cancerous cells
Neoplasia, derived from the Greek "neo" (new) and "plasia" (formed or moulded), refers to the process of abnormal growth that starts from a single altered cell. Neoplastic transformation is initiated by an insult to a normal cell, which could be from an exogenous agent (such as a chemical carcinogen or radiation) or an endogenous source (such as reactive oxygen species). This initial insult leads to genetic alterations and/or epigenetic changes, resulting in selective clonal expansion and the development of a preneoplastic lesion.
Genetic and epigenetic lesions are integral parts of the neoplastic transformation process. Genomic instability, a common occurrence during neoplastic disease development, can lead to various molecular alterations, including gene amplifications, deletions, insertions, rearrangements, and point mutations. Epigenetic alterations, or epimutations, can also play a role in cancer development. For example, genome-wide hypomethylation of DNA may induce oncogene expression, while gene-specific hypermethylation events can silence tumour suppressor genes, leading to uncontrolled cell growth.
The development of cancer is a multistep process, with cells gradually becoming malignant through a series of progressive alterations. The first step, tumour initiation, is triggered by a genetic alteration leading to the abnormal proliferation of a single cell. This cell proliferation results in the formation of a population of clonally derived tumour cells, which continue to evolve and become dominant through additional mutations. These mutations can confer selective advantages, such as more rapid growth, contributing to the progression of the tumour.
Neoplastic cells must develop the capacity to invade before they can metastasize. Metastasis occurs when cancer cells break away from the original tumour and travel through the blood or lymph system to distant locations, forming additional tumours. This spread can happen through various routes, including direct seeding into body cavities, lymphogenous spread, hematogenous spread, and implantation or inoculation during medical procedures.
While cancer is a collection of diseases with various manifestations, certain biological properties are common among the cells that compose the tumours. These include unregulated (clonal) cell growth, impaired cellular differentiation, invasiveness, and metastatic potential. Understanding the cellular and molecular aspects of the cancer process requires a grasp of the pathological terms involved in defining and describing neoplasia and carcinogenesis.
Plastic Ban: Economic Impact and Environmental Benefits
You may want to see also
Explore related products
Neoplastic disease: A multi-step process where cells acquire increasingly abnormal behaviours, leading to cancer
Neoplastic disease is a multi-step process where cells acquire increasingly abnormal behaviours, ultimately leading to cancer. The term 'neoplastic' comes from the Greek 'neo', meaning 'new', and 'plastic', meaning 'formed' or 'moulded'.
Neoplasia, or the neoplastic process, refers to the formation of neoplasms or tumours. A neoplasm is an abnormal growth of cells, which can be solid or fluid-filled and may or may not be formed by an abnormal growth of neoplastic cells. Tumours are often used synonymously with neoplasms, though some neoplasms do not form tumours, such as leukaemia and most forms of carcinoma in situ. Tumours can be benign (non-cancerous), precancerous, or malignant (cancerous). Malignant tumours have the capacity to invade surrounding normal tissue and metastasise, or spread to other parts of the body.
The development of neoplastic disease begins with an insult to a normal cell, which could be from an exogenous agent, such as a chemical carcinogen or radiation, or from an endogenous source, such as reactive oxygen species. This initial insult leads to genetic alterations and/or epigenetic changes, resulting in a preneoplastic lesion. With further genetic and epigenetic changes, cells with invasive potential emerge and form a malignant tumour. Cancer is then able to develop with additional alterations, and can spread to other sites in the body through metastasis.
The progression from a benign lesion to a malignant neoplasm occurs in distinct stages, including benign adenoma, carcinoma in situ, invasive carcinoma, local invasion, and distant metastasis. Specific genetic alterations have been correlated with each of these histopathologic stages of tumour development. Cancer is a collection of diseases with various manifestations, but all cancerous states share certain biological properties, including unregulated cell growth, impaired cellular differentiation, invasiveness, and metastatic potential.
Generating Electricity from Plastic: A Viable Solution?
You may want to see also
Explore related products
Neoplastic cells and metastasis: Neoplastic cells must develop the capacity to invade before they can spread to other parts of the body
The neoplastic process refers to the formation of neoplasms or tumors, with the term neoplasia denoting the process of abnormal growth that starts from a single altered cell. Neoplastic transformation is initiated by an insult to a normal cell, which could be from an exogenous agent such as radiation or an endogenous source like reactive oxygen species. This initial insult leads to genetic alterations and epigenetic changes, resulting in selective clonal expansion and the development of a preneoplastic lesion.
Neoplastic cells must develop the capacity to invade before they can spread to other parts of the body, a process known as metastasis. Metastasis is the dissemination of cells away from the originating tumor, and it occurs when cancer cells migrate throughout the body and form new tumors. While the exact reason for cancer cells leaving the initial site of growth is unclear, it is suggested that harsh conditions inside the tumor, such as defective blood supply, lack of oxygen, and nutrient deficiency, may trigger cancer cell death and subsequent migration.
Cancer cells can invade blood and lymphatic vessels, using these circulatory systems to move to distant locations. The circulatory system is the primary route for cancer cells to spread to distant organs, while the lymphatic system provides a pathway to local lymph nodes, which then connect with the circulatory system for further dissemination. This process is known as lymphogenous spread and is commonly observed in melanoma, breast, lung, and gastrointestinal tumors.
Additionally, metastasis can occur through the spread of malignancy into body cavities, such as the peritoneal, pleural, pericardial, or subarachnoid spaces. This is achieved by degrading proteins that make up the surrounding extracellular matrix (ECM), allowing cancer cells to breach the ECM and escape. The formation of metastatic loci is not a binary process, and neoplastic cells can adapt and reside anywhere along the continuum of states between epithelial and mesenchymal phenotypes.
Furthermore, cancer cells can release exosomes, which are small sacs that can travel through the body and facilitate the colonization of new areas. This release of exosome vesicles is a critical factor in the invasion-metastasis cascade, as they can home in on pre-metastatic sites and create a favorable microenvironment for secondary tumor growth. The ability to adapt and respond to new environments is essential for neoplastic cells to successfully metastasize.
Plastic Cable Ties: How Do They Lock?
You may want to see also
Explore related products
$298.02 $329.99
Neoplastic growth: Angiogenesis, or the formation of new blood vessels, is a critical mediator of neoplastic growth, supplying nutrients and oxygen
Neoplastic growth refers to the abnormal growth of neoplasms or tumours. Neoplasia, derived from the Greek 'neo' for 'new' and 'plasia' for 'formed, moulded', is the process of abnormal growth that starts from a single altered cell. Neoplasms are abnormal masses of tissue that result when cells divide more than they should or do not die when they should. They are often heterogeneous and contain more than one type of cell, but their growth is usually dependent on a single population of neoplastic cells. These cells are presumed to be monoclonal, derived from the same cell, and all carry the same genetic or epigenetic anomaly.
Neoplastic transformation is initiated by an insult to a normal cell, which could be from an exogenous agent such as a chemical carcinogen or radiation, or from an endogenous source such as reactive oxygen species. This initial insult leads to genetic alterations and/or epigenetic changes, followed by selective clonal expansion of the cell population to give a preneoplastic lesion. With further genetic and epigenetic changes, cells with invasive potential emerge and a malignant tumour forms.
Angiogenesis, the formation of new blood vessels, is a critical mediator of neoplastic growth as it supplies nutrients and oxygen. It is a normal and vital physiological process that supports wound healing and supplies oxygen-rich blood to organs and tissues. However, in the context of cancer, angiogenesis facilitates tumour growth and spread. Tumours induce angiogenesis by secreting growth factors and proteins, which trigger the formation of new capillaries from pre-existing blood vessels. This provides the blood supply that tumours need to grow beyond a certain size.
The extent of angiogenesis has been correlated with the probability of metastasis in neoplasms. Angiogenesis inhibitors are medications that have been developed to block the process of new blood vessel formation, thereby inhibiting tumour growth.
Transforming Plastic with Decoupage: A Beginner's Guide
You may want to see also
Frequently asked questions
Neoplastic, derived from the Greek neo ('new') and plastic ('formed, moulded'), refers to the process of abnormal growth that starts from a single altered cell. This process is also known as neoplasia or the formation of neoplasms/tumours. Neoplasms are abnormal masses of tissue that result when cells divide more than they should or do not die when they should.
Neoplastic transformation is initiated by an insult to a normal cell, which could be from an exogenous agent (e.g. a chemical carcinogen or radiation) or an endogenous source (e.g. reactive oxygen species). This initial insult leads to genetic alterations and/or epigenetic changes, resulting in selective clonal expansion and the development of a preneoplastic lesion.
Neoplastic cells must first develop the capacity to invade before they can metastasize. This occurs when additional genetic and epigenetic changes cause cells to become invasive and form malignant tumours. Cancer is then able to develop when further changes occur, allowing it to spread to metastatic sites.
